2024 Q4 Form 10-Q Financial Statement

#000143774924034670 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $14.44M
YoY Change 24.84%
Cost Of Revenue $7.853M
YoY Change 25.35%
Gross Profit $6.589M
YoY Change 24.25%
Gross Profit Margin 45.62%
Selling, General & Admin $5.453M
YoY Change 38.65%
% of Gross Profit 82.76%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.132M
YoY Change 39.24%
% of Gross Profit 17.18%
Operating Expenses $5.453M
YoY Change 6.03%
Operating Profit $1.136M
YoY Change 610.0%
Interest Expense -$901.0K
YoY Change -222.75%
% of Operating Profit -79.31%
Other Income/Expense, Net -$890.0K
YoY Change -57.74%
Pretax Income $246.0K
YoY Change -112.64%
Income Tax $192.0K
% Of Pretax Income 78.05%
Net Earnings $54.00K
YoY Change -102.8%
Net Earnings / Revenue 0.37%
Basic Earnings Per Share $0.01
Diluted Earnings Per Share $0.01
COMMON SHARES
Basic Shares Outstanding 10.45M 10.45M
Diluted Shares Outstanding 10.63M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $868.0K
YoY Change -89.64%
Cash & Equivalents $868.0K
Short-Term Investments
Other Short-Term Assets $743.0K
YoY Change -22.6%
Inventory $3.054M
Prepaid Expenses
Receivables $11.30M
Other Receivables $0.00
Total Short-Term Assets $15.97M
YoY Change -8.81%
LONG-TERM ASSETS
Property, Plant & Equipment $369.0K
YoY Change -28.07%
Goodwill $26.45M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $355.0K
YoY Change 725.58%
Total Long-Term Assets $51.60M
YoY Change -1.12%
TOTAL ASSETS
Total Short-Term Assets $15.97M
Total Long-Term Assets $51.60M
Total Assets $67.56M
YoY Change -3.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.446M
YoY Change 92.99%
Accrued Expenses $3.649M
YoY Change -18.89%
Deferred Revenue $2.769M
YoY Change -21.04%
Short-Term Debt $10.79M
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $27.52M
YoY Change 39.94%
LONG-TERM LIABILITIES
Long-Term Debt $10.71M
YoY Change 1.29%
Other Long-Term Liabilities $309.0K
YoY Change 76.57%
Total Long-Term Liabilities $11.02M
YoY Change 2.51%
TOTAL LIABILITIES
Total Short-Term Liabilities $27.52M
Total Long-Term Liabilities $11.02M
Total Liabilities $39.27M
YoY Change -7.14%
SHAREHOLDERS EQUITY
Retained Earnings -$54.02M
YoY Change -1.37%
Common Stock $104.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $28.29M
YoY Change
Total Liabilities & Shareholders Equity $67.56M
YoY Change -3.05%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $54.00K
YoY Change -102.8%
Depreciation, Depletion And Amortization $1.132M
YoY Change 39.24%
Cash From Operating Activities $544.0K
YoY Change -72.33%
INVESTING ACTIVITIES
Capital Expenditures $807.0K
YoY Change -13.97%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$807.0K
YoY Change -13.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.955M
YoY Change -172.34%
NET CHANGE
Cash From Operating Activities 544.0K
Cash From Investing Activities -807.0K
Cash From Financing Activities -2.955M
Net Change In Cash -3.218M
YoY Change -162.94%
FREE CASH FLOW
Cash From Operating Activities $544.0K
Capital Expenditures $807.0K
Free Cash Flow -$263.0K
YoY Change -125.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
CREATIVE REALITIES, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001356093
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
66666000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
66666000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10447000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10447000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10409000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10409000
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4587002
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33169
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MN
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
41-1967918
dei Entity Address Address Line1
EntityAddressAddressLine1
13100 Magisterial Drive, Suite 100,
dei Entity Address City Or Town
EntityAddressCityOrTown
Louisville
dei Entity Address State Or Province
EntityAddressStateOrProvince
KY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
40223
dei City Area Code
CityAreaCode
502
dei Local Phone Number
LocalPhoneNumber
791-8800
dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
dei Trading Symbol
TradingSymbol
CREX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10446659
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
868000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2910000 usd
CY2024Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
11300000 usd
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
12468000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3054000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2567000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
743000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
665000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
15965000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
18610000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
369000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
499000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
26453000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
26453000 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
23519000 usd
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
24062000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
901000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1041000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
355000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
112000 usd
CY2024Q3 us-gaap Assets
Assets
67562000 usd
CY2023Q4 us-gaap Assets
Assets
70777000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6446000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7876000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3649000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3761000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
2769000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1132000 usd
CY2024Q3 crex Customer Deposit Current
CustomerDepositCurrent
3398000 usd
CY2023Q4 crex Customer Deposit Current
CustomerDepositCurrent
3233000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
461000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
505000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10794000 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
27517000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
20197000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
463000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
536000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
11208000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
309000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
176000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
39268000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
41946000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
104000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
104000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82206000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82073000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-54016000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-53346000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
28294000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
28831000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
67562000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70777000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14442000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11568000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39842000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
30708000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7853000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6265000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20701000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16018000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
6589000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
5303000 usd
us-gaap Gross Profit
GrossProfit
19141000 usd
us-gaap Gross Profit
GrossProfit
14690000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1525000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1301000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4655000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3666000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3928000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3842000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12834000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11654000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
5453000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5143000 usd
us-gaap Operating Expenses
OperatingExpenses
17489000 usd
us-gaap Operating Expenses
OperatingExpenses
15320000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1136000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
160000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1652000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-630000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
303000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
734000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1479000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2324000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
598000 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1369000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-414000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1461000 usd
CY2024Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1059000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
132000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-890000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2106000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2096000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3653000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
246000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1946000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-444000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4283000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
226000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
54000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1931000 usd
us-gaap Net Income Loss
NetIncomeLoss
-670000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4356000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.56
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.56
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10447000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8713000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10438000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7775000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10634000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8713000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10438000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7775000
us-gaap Net Income Loss
NetIncomeLoss
-670000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4356000 usd
crex Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium
2901000 usd
crex Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium
DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium
2393000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
569000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1078000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
9000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
539000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
37000 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1059000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
186000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
318000 usd
us-gaap Inventory Write Down
InventoryWriteDown
-65000 usd
us-gaap Inventory Write Down
InventoryWriteDown
141000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-414000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1461000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
157000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
44000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-982000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2080000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
422000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
180000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
78000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-859000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1360000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-53000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
8000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
683000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1637000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2284000 usd
crex Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
165000 usd
crex Increase Decrease In Customer Deposit
IncreaseDecreaseInCustomerDeposit
1054000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-49000 usd
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
39000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4750000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
8306000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
287000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2293000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
2851000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2302000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3138000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5454000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
21854000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10875000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
289000 usd
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
-0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
15147000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3865000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
33000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
14000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4490000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1575000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2042000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6743000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2910000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1633000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
868000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8376000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
28237000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
54000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
28294000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
28831000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
124000 usd
us-gaap Net Income Loss
NetIncomeLoss
-670000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
28294000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
23858000 usd
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5454000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1931000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
27403000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
25579000 usd
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
139000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5454000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4356000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
27403000 usd
CY2024Q3 crex Working Capital
WorkingCapital
11552000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1136000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1652000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4750000 usd
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
10794000 usd
CY2024Q3 crex Line Of Credit Facility Contingent Consideration Reserve Value
LineOfCreditFacilityContingentConsiderationReserveValue
4000000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
701000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
984000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
186000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
318000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
228000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
886000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1074000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
2020000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2063000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
1034000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
504000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
3054000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2567000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6219244
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7391651
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3363741
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7391651
CY2024Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><em style="font: inherit;">10.</em> Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our significant estimates include: valuation of the contingent consideration, allowance for credit losses, valuation allowances related to deferred taxes, the fair value of acquired assets and liabilities, the fair value of liabilities reliant upon the appraised fair value of the Company, valuation of stock-based compensation awards and other assumptions and estimates used to evaluate the recoverability of long-lived assets, goodwill and other intangible assets and the related amortization methods and periods. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4 crex Business Acquisition Extension Option Minimum Extension Threshold Price Increase In Price
BusinessAcquisitionExtensionOptionMinimumExtensionThresholdPriceIncreaseInPrice
1
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14442000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11568000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
39842000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
30708000 usd
crex Capitalized Software In Accounts Payable
CapitalizedSoftwareInAccountsPayable
114000 usd
crex Capitalized Software In Accounts Payable
CapitalizedSoftwareInAccountsPayable
211000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
13000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
154000 usd
crex Capitalized Deferred Financing Costsin Accounts Payable
CapitalizedDeferredFinancingCostsinAccountsPayable
17000 usd
crex Capitalized Deferred Financing Costsin Accounts Payable
CapitalizedDeferredFinancingCostsinAccountsPayable
0 usd
us-gaap Interest Paid Net
InterestPaidNet
933000 usd
us-gaap Interest Paid Net
InterestPaidNet
1303000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
442000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
566000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
46000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
48000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
35640000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12121000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
33464000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9402000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12121000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9402000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
23519000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
24062000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1081000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
766000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2749000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2274000 usd
CY2024Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
10979000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15147000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
269000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1628000 usd
CY2024Q3 us-gaap Long Term Debt
LongTermDebt
10710000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
13519000 usd
CY2024Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3690000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10710000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9829000 usd
CY2024Q3 crex Floating Margin At Less Than11 Senior Funded Debt To Ebitda Ratio
FloatingMarginAtLessThan11SeniorFundedDebtToEbitdaRatio
0.02 pure
CY2024Q3 crex Floating Margin At Greater Or Equal To11 But Less Than21 Senior Funded Debt To Ebitda Ratio
FloatingMarginAtGreaterOrEqualTo11ButLessThan21SeniorFundedDebtToEbitdaRatio
0.025 pure
CY2024Q3 crex Floating Margin At Greater Or Equal To21 But Less Than31 Senior Funded Debt To Ebitda Ratio
FloatingMarginAtGreaterOrEqualTo21ButLessThan31SeniorFundedDebtToEbitdaRatio
0.03 pure
CY2024Q3 crex Floating Margin At Greater Or Equal To31 Senior Funded Debt To Ebitda Ratio
FloatingMarginAtGreaterOrEqualTo31SeniorFundedDebtToEbitdaRatio
0.035 pure
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-15000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
226000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
73000 usd
CY2024Q3 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
229000 usd
CY2023Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
73000 usd
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4587002
crex Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P3Y4M9D
CY2023 crex Class Of Warrant Or Right Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm
P4Y1M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y4M9D

Files In Submission

Name View Source Status
0001437749-24-034670-index-headers.html Edgar Link pending
0001437749-24-034670-index.html Edgar Link pending
0001437749-24-034670.txt Edgar Link pending
0001437749-24-034670-xbrl.zip Edgar Link pending
crex-20240930.xsd Edgar Link pending
crex20240930c_10q.htm Edgar Link pending
crexlogonew.jpg Edgar Link pending
ex_723215.htm Edgar Link pending
ex_723216.htm Edgar Link pending
ex_723217.htm Edgar Link pending
ex_723218.htm Edgar Link pending
ex_746609.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
crex-20240930_def.xml Edgar Link unprocessable
crex-20240930_lab.xml Edgar Link unprocessable
crex-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
crex20240930c_10q_htm.xml Edgar Link completed
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
crex-20240930_cal.xml Edgar Link unprocessable